Cap43/NDRG1/Drg-1 is a molecular target for angiogenesis and a prognostic indicator in cervical adenocarcinoma.

[1]  D. Richardson,et al.  The metastasis suppressor, Ndrg-1: a new ally in the fight against cancer. , 2006, Carcinogenesis.

[2]  M. Kuwano,et al.  Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis. , 2006, Cancer research.

[3]  N. Imamoto,et al.  The 70-kD heat shock cognate protein (hsc70) facilitates the nuclear export of the import receptors , 2005, The Journal of cell biology.

[4]  K. Keum,et al.  Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix. , 2004, International journal of radiation oncology, biology, physics.

[5]  M. Kuwano,et al.  N‐myc downstream‐regulated gene 1 expression in injured sciatic nerves , 2004, Glia.

[6]  Ken Saito,et al.  Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression , 2004, Oncogene.

[7]  M. Murakami,et al.  N-myc downregulated gene 1 is a phosphorylated protein in mast cells. , 2004, Biological & pharmaceutical bulletin.

[8]  D. Polsky,et al.  Altered N-myc Downstream-Regulated Gene 1 Protein Expression in African-American Compared with Caucasian Prostate Cancer Patients , 2004, Clinical Cancer Research.

[9]  T. Iwaki,et al.  Cellular Distribution of NDRG1 Protein in the Rat Kidney and Brain During Normal Postnatal Development , 2003, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[10]  T. Shuin,et al.  Downregulation of Cap43 gene by von Hippel‐Lindau tumor suppressor protein in human renal cancer cells , 2003, International journal of cancer.

[11]  P. Carmeliet.  Angiogenesis in health and disease , 2003, Nature Medicine.

[12]  K. Miura,et al.  The Drg-1 gene suppresses tumor metastasis in prostate cancer. , 2003, Cancer research.

[13]  F. Bosman,et al.  Expression of NDRG1, a differentiation-related gene, in human tissues , 2002, Histochemistry and Cell Biology.

[14]  J. Folkman,et al.  Clinical translation of angiogenesis inhibitors , 2002, Nature Reviews Cancer.

[15]  B. Rosen,et al.  Does histology influence prognosis in patients with early‐stage cervical carcinoma? , 2001, Cancer.

[16]  C. West,et al.  Tumor vascularity: a histological measure of angiogenesis and hypoxia. , 2001, Cancer research.

[17]  T. Miyata,et al.  Characterization of the human NDRG gene family: a newly identified member, NDRG4, is specifically expressed in brain and heart. , 2001, Genomics.

[18]  J. Monson,et al.  Pre-operative serum vascular endothelial growth factor can select patients for adjuvant treatment after curative resection in colorectal cancer , 2000, British Journal of Cancer.

[19]  C. Key,et al.  The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States--a 24-year population-based study. , 2000, Gynecologic oncology.

[20]  K. Agarwala,et al.  Phosphorylation of RTP, an ER stress-responsive cytoplasmic protein. , 2000, Biochemical and biophysical research communications.

[21]  T. Fukuda,et al.  High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma , 2000, Cancer.

[22]  S. Finkelstein,et al.  Well-Differentiated Villoglandular Adenocarcinoma of the Uterine Cervix: Oncogene/Tumor Suppressor Gene Alterations and Human Papillomavirus Genotyping , 2000, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[23]  H. Kondoh,et al.  Identification of new genes ndr2 and ndr3 which are related to Ndr1/RTP/Drg1 but show distinct tissue specificity and response to N-myc. , 1999, Biochemical and biophysical research communications.

[24]  Y. Kotake,et al.  Enhanced expression of Tie2, its ligand angiopoietin-1, vascular endothelial growth factor, and CD31 in human non-small cell lung carcinomas. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[25]  J. Swinnen,et al.  The differentiation‐related gene 1, Drg1, is markedly upregulated by androgens in LNCaP prostatic adenocarcinoma cells , 1999, FEBS letters.

[26]  H. Kondoh,et al.  N-myc-dependent repression of Ndr1, a gene identified by direct subtraction of whole mouse embryo cDNAs between wild type and N-myc mutant , 1999, Mechanisms of Development.

[27]  S. Roberts,et al.  High tumor angiogenesis is associated with poorer survival in carcinoma of the cervix treated with radiotherapy. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[28]  S. Aaronson,et al.  Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage. , 1998, Cancer research.

[29]  N. Kinukawa,et al.  Angiogenesis in adenocarcinoma of the uterine cervix , 1998, Cancer.

[30]  K. Salnikow,et al.  Cap43, a novel gene specifically induced by Ni2+ compounds. , 1998, Cancer research.

[31]  V. Moreno,et al.  International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas , 1998, International journal of cancer.

[32]  W. Dinjens,et al.  A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[33]  M. Quinn.  Adenocarcinoma of the cervix--are there arguments for a different treatment policy? , 1997, Current opinion in obstetrics & gynecology.

[34]  T. Miyata,et al.  Homocysteine-respondent Genes in Vascular Endothelial Cells Identified by Differential Display Analysis , 1996, The Journal of Biological Chemistry.

[35]  P. Boyle,et al.  The continuing increase in adenocarcinoma of the uterine cervix: a birth cohort phenomenon. , 1996, International journal of epidemiology.

[36]  R. Newcombe,et al.  Primary adenocarcinoma of the cervix. A clinicopathologic study of prognostic variables in 55 cases , 1994, International Journal of Gynecologic Cancer.

[37]  T. Kaku,et al.  Early adenocarcinoma of the uterine cervix--its histologic and immunohistologic study. , 1989, Gynecologic oncology.

[38]  D. Ross,et al.  Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma , 2007, Modern Pathology.

[39]  Fuchu He,et al.  Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family , 2004, Molecular and Cellular Biochemistry.

[40]  S. Ciatto,et al.  Increasing trends of cervical adenocarcinoma incidence in Central Italy despite Extensive Screening Programme, 1985-2000. , 2004, Cancer Detection and Prevention.

[41]  増田 克明.  Downregulation of Cap43 gene by von Hippel-Lindau tumor suppressor protein in human renal cancer cells , 2003 .

[42]  B. Fine,et al.  VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma. , 2000, Gynecologic oncology.

[43]  J. Folkman.  Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.